During the past decade, Curatio JSC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Curatio JSC" #1 sponsor was "Celgene" with 2 trials, followed by "Optinose US Inc." with 2 trials sponsored, "Actelion" with 1 trials sponsored, "AiCuris Anti-infective Cures AG" with 1 trials sponsored and "Reistone Biopharma Company Limited" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Curatio JSC" #1 collaborator was "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Curatio JSC" are "Multiple Sclerosis" (3 trials), "Chronic Rhinosinusitis" (2 trials), "HSV Infection" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Curatio JSC" in a lesser frequency.

Most popular intervention types in "Curatio JSC" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "OPN-375" (2 trials), "Foscarnet" (1 trials), "Interferon beta-1a" (1 trials), "Ozanimod" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Curatio JSC" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Curatio JSC". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Curatio JSC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Curatio JSC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".